**Kindly note that this meeting is open only to members of the European Chamber Pharmaceutical and Healthcare Equipment Working Groups.
The European Chamber is delighted to invite you to an online WG Meeting on Interpretation of the Implementation Regulations of the Drug Administration Law draft revisions / 《药品管理法实施条例》征求意见稿解读, to be held on Monday, 6th June, 14.00 – 16.00.
The National Medical Products Administration (NMPA) recently released the Implementation Regulations of the Drug Administration Law (Draft Revisions) for public consultation in May and June. For the full draft in Chinese, please visit 国家药监局公开征求《中华人民共和国药品管理法实施条例(修订草案征求意见稿)》意见.
The Draft Revisions introduced important changes since the promulgation of the Drug Administration Law in 2019. Given its significance, the European Chamber is honoured to invite Mr Andrew Chen, managing partner of Arnold & Porter LLP Shanghai Office, to give interpretations and share his insights. Mr Chen has over 20 years of experience in drug and food law, including serving in the US FDA and Amgen, and has been assisting the NMPA on a pro bono basis.
Agenda
14.00 – 14.10 Opening Remarks by Pharmaceutical WG National Chair, Mr Raphael de Garner des Garets
14.10 – 15.10 Presentation by Mr Andrew Chen
15.10 – 15.55 Q&A
15.55 – 16.00 Closing Remarks
Please note that the presentation will be in Chinese due to the highly technical nature of the draft revisions. The Q&A will be bilingual in English and Chinese. If you are an English speaker and wish to participate in this WG meeting, please send your questions in English in advance – Mr Chen will help address these questions during Q&A, and you can dial in then.
Please register before Friday, 3rd June, COB. Zoom link will be shared before the meeting.